This project has been flagged by a community member as inappropriate due to reason below.*

Expert Interview

Slingshot members are talking to an expert! The topic is:

Examining the data presented on aficamten in non-obstructive hypertrophic cardiomyopathy by Cytokinetics Biopharma

Ticker(s): CYTK

Who's the expert?

Institution: Bay Area Cardiology

  • Clinical Cardiologist who has been in practice for 16 years with a Fellowship focused in Clinical Cardiac Electrophysiology from Duke University.
  • Treats approximately 100+ heart failure patients in both inpatient and outpatient locations monthly, and manages 65 hypertrophic cardiomyopathy patients with 25 being non-obstructive
  • Skilled in Complex ablations, Defibrillator, Medical Devices, Catheters, and Cardiac Electrophysiology.

Interview Goal
This interview will focus on discussing the data presented by Cytokinetics Biopharma that examines the potential of  treating patients with non-obstructive hypertrophic cardiomyopathy with aficamten.

Are You Interested In These Questions?

Slingshot Insights Explained

Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.


*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.